Skip to main content
SP5007,674.37+0.43%DOW53,277.01+0.98%NASDAQ26,180.46+0.43%BTC$77,812.00+5.53%ETH$2,513.75+7.22%GOLD$4,661.60+1.97%OIL$86.64-0.22%
Smart Investors Daily
Sign InSign Up Free
HS

NASDAQ · HSAQ

Health Sciences Acquisitions Corporation 2

Financial Services · Shell Companies

$13.31

Up+$2.59 (+24.16%)

Updated Aug 23, 2026, 4:33 PM

SID Score

—

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
149.23M
P/E ratio
-8.16
Dividend yield
0.00%
52-week range
— – —
Volume
119.61K
Avg. volume
74.74K

Price performance

HSAQ price history

1M range · 0 trading sessions · Daily adjusted prices

HSAQ does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest HSAQ news

The latest Smart Investors Daily articles mentioning HSAQ.

Stock researchCompany · Overview

HSAQ research

Overview

Company profile and research snapshot.

Company profile

Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Benzinga · Jul 26, 2022

$10 Million Bet On This Financial Services Stock? 3 Stocks Insiders Are Buying

Although US stocks closed mixed on Monday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform. Baker Hughes Company The Trade: Baker Hughes Company (NASDAQ: BKR) Director Michael Dumais acquired a total of 10,000 shares at ...

Benzinga · Apr 30, 2021

Earnings Scheduled For April 30, 2021

Companies Reporting Before The Bell • O2Micro Intl (NASDAQ:OIIM) is estimated to report quarterly earnings at $0.09 per share on revenue of $23.30 million. • Twin Disc (NASDAQ:TWIN) is likely to report quarterly loss at $0.12 per share on revenue of $57.70 million. • L3Harris Technologies (NYSE:LHX) is projected to report quarterly earnings at $2.94 per share on revenue of $4.54 billion. • Shell Midstream Partners (NYSE:SHLX) is expected to report quarterly earnings at $0.34 per share on revenue of $123.97 million. • Cboe Global Markets (BATS:CBOE) is estimated to report quarterly earnings at $1.40 per share on revenue of $353.75 million. • Quhuo (NASDAQ:QH) is estimated to report quarterly earnings at $0.11 per share on revenue of $117.20 million. • Pitney Bowes (NYSE:PBI) is expected to report quarterly earnings at $0.04 per share on revenue of $873.86 million. • Weyerhaeuser (NYSE:WY) is likely to report quarterly earnings at $0.91 per share on revenue of $2.52 billion. • iRadimed (NASDAQ:IRMD) is estimated to report quarterly earnings at $0.10 per share on revenue of $8.56 million. • BeyondSpring (NASDAQ:BYSI) is projected to report earnings for its fourth quarter. • Portland General Electric (NYSE:POR) is likely to report quarterly earnings at $0.92 per share on revenue of $578.16 million. • Newell Brands (NASDAQ:NWL) is estimated to report quarterly earnings at $0.13 per share on revenue of $2.07 billion. • Carter's (NYSE:CRI) is projected to report quarterly earnings at $0.32 per share on revenue of $664.49 million. • Huntsman (NYSE:HUN) is likely to report quarterly earnings at $0.59 per share on revenue of $1.75 billion. • Clorox (NYSE:CLX) is estimated to report quarterly earnings at $1.48 per share on revenue of $1.87 billion. • Colgate-Palmolive (NYSE:CL) is expected to report quarterly earnings at $0.79 per share on revenue of $4.25 billion. • Goodyear Tire & Rubber (NASDAQ:GT) is estimated to report quarterly earnings at $0.09 per share on revenue of $3.40 billion. • Exxon Mobil (NYSE:XOM) is projected to report quarterly earnings at $0.59 per share on revenue of $54.60 billion. • AstraZeneca (NASDAQ:AZN) is estimated to report ...Full story available on Benzinga.com

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By